Polymers for Cardiovascular Stent Coatings

International Journal of Polymer Science

Volumn 2015, Issue , 2015, Pages

  Strohbach, Anne ^a,b   Busch, Raila ^a,b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; BIODEGRADABLE POLYMERS; BLOOD; DISEASES; MORPHOLOGY; PHYSIOLOGICAL MODELS; STENTS;

CARDIOVASCULAR APPLICATIONS; CARDIOVASCULAR STENTS; CELL MORPHOLOGY; DRUG-ELUTING STENTS; HYPERSENSITIVITY REACTION; IN-STENT RESTENOSIS; PHYSIOLOGICAL CONDITION; VASCULAR INTERVENTIONS;

PLASTIC COATINGS;

EID: 84932623970     PISSN: 16879422     EISSN: 16879430     Source Type: Journal    
DOI: 10.1155/2015/782653     Document Type: Review

References (123)

1. G. Krenning, M. J. A. van Luyn, and M. C. Harmsen, "Endothelial progenitor cell-based neovascularization: implications for therapy," Trends in Molecular Medicine, vol. 15, no. 4, pp. 180-189, 2009.
2. T. Liu, S. Liu, K. Zhang, J. Chen, and N. Huang, "Endothelialization of implanted cardiovascular biomaterial surfaces: the development from in vitro to in vivo," Journal of Biomedical Materials Research Part A, vol. 102, no. 10, pp. 3754-3772, 2014.
3. C. Rogers, D.Y. Tseng, J.C. Squire, and E. R. Edelman, "Balloonartery interactions during stent placement: a finite element analysis approach to pressure, compliance, and stent design as contributors to vascular injury," Circulation Research, vol. 84, no. 4, pp. 378-383, 1999.
4. P. Wenaweser, C. Rey, F. R. Eberli et al., "Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome," European Heart Journal, vol. 26, no. 12, pp. 1180-1187, 2005.
5. S. Windecker and B. Meier, "Late coronary stent thrombosis," Circulation, vol. 116, no. 17, pp. 1952-1965, 2007.
6. T. C. Woods and A. R. Marks, "Drug-eluting stents," Annual Review of Medicine, vol. 55, pp. 169-178, 2004.
7. A. Farb, A. P. Burke, F. D. Kolodgie, and R. Virmani, "Pathological mechanisms of fatal late coronary stent thrombosis in humans," Circulation, vol. 108, no. 14, pp. 1701-1706, 2003.
8. M. Joner, A. V. Finn, A. Farb et al., "Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk," Journal of the American College of Cardiology, vol. 48, no. 1, pp. 193-202, 2006.
9. P. Lanzer, K. Sternberg, K.-P. Schmitz, F. Kolodgie, G. Nakazawa, and R. Virmani, "Drug-eluting coronary stent very late thrombosis revisited," Herz, vol. 33, no. 5, pp. 334-342, 2008.
10. R. A. Byrne, J. Mehilli, R. Iijima et al., "A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents," European Heart Journal, vol. 30, no. 8, pp. 923-931, 2009.
11. R. Virmani, F. D. Kolodgie, and A. Farb, "Drug-eluting stents: are they really safe?" The American Heart Hospital Journal, vol. 2, no. 2, pp. 85-88, 2004.
12. J. R. Nebeker, R. Virmani, C. L. Bennett et al., "Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project," Journal of the American College of Cardiology, vol. 47, no. 1, pp. 175-181, 2006.
13. S. Garg and P. W. Serruys, "Coronary stents: looking forward," Journal of the American College of Cardiology, vol. 56, no. 10, pp. S43-S78, 2010.
14. C. M. Campos, T. Muramatsu, J. Iqbal et al., "Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease," International Journal of Molecular Sciences, vol. 14, no. 12, pp. 24492-24500, 2013.
15. R. Waksman, "Biodegradable stents: they do their job and disappear," The Journal of Invasive Cardiology, vol. 18, no. 2, pp. 70-74, 2006.
16. S. Brugaletta, H. M. Garcia-Garcia, Y. Onuma, and P. W. Serruys, "Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives," Expert Review of Medical Devices, vol. 9, no. 4, pp. 327-338, 2012.
17. P. W. Serruys, H. M. Garcia-Garcia, and Y. Onuma, "From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade?" European Heart Journal, vol. 33, no. 1, pp. 16-25, 2011.
18. J. P. Theron, J. H. Knoetze, R. D. Sanderson et al., "Modification, crosslinking and reactive electrospinning of a thermoplastic medical polyurethane for vascular graft applications," Acta Biomaterialia, vol. 6, no. 7, pp. 2434-2447, 2010.
19. Z.-J. Hu, Z.-L. Li, L.-Y. Hu et al., "The in vivo performance of small-caliber nanofibrous polyurethane vascular grafts," BMC Cardiovascular Disorders, vol. 12, article 115, 2012.
20. W. He, Z. Hu, A. Xu et al., "The preparation and performance of a new polyurethane vascular prosthesis," Cell Biochemistry and Biophysics, vol. 66, no. 3, pp. 855-866, 2013.
21. J. Han, S. Farah, A. J. Domb, and P. I. Lelkes, "Electrospun rapamycin-eluting polyurethane fibers for vascular grafts," Pharmaceutical Research, vol. 30, no. 7, pp. 1735-1748, 2013.
22. C. K. S. Pillai and C. P. Sharma, "Review paper: absorbable polymeric surgical sutures: chemistry, production, properties, biodegradability, and performance," Journal of Biomaterials Applications, vol. 25, no. 4, pp. 291-366, 2010.
23. N. Diban, S. Haimi, L. Bolhuis-Versteeg et al., "Hollow fibers of poly(lactide-co-glycolide) and poly(∈-caprolactone) blends for vascular tissue engineering applications," Acta Biomaterialia, vol. 9, no. 5, pp. 6450-6458, 2013.
24. F. Yi, H. Wu, and G.-L. Jia, "Formulation and characterization of poly (D, L-lactide-co-glycolide) nanoparticle containing vascular endothelial growth factor for gene delivery," Journal of Clinical Pharmacy and Therapeutics, vol. 31, no. 1, pp. 43-48, 2006.
25. S. A. Yehia, A. H. Elshafeey, and I. Elsayed, "Anovel injectable in situ forming poly-DL-lactide and DL-lactide/glycolide implant containing lipospheres for controlled drug delivery," Journal of Liposome Research, vol. 22, no. 2, Article ID631141, pp. 128-138, 2012.
26. I. Amjadi, M. Rabiee, M. S. Hosseini, and M. Mozafari, "Synthesis and characterization of doxorubicin-loaded poly(lactide-coglycolide) nanoparticles as a sustained-release anticancer drug delivery system," Applied Biochemistry and Biotechnology, vol. 168, no. 6, pp. 1434-1447, 2012.
27. M. van Alst, M. J. D. Eenink, M.-A. B. Kruft, and R. Van Tuil, "ABC's of bioabsorption: application of lactide based polymers in fully resorbable cardiovascular stents," Euro Intervention, vol. 5, pp. F23-F27, 2009.
28. Y. Onuma, D. Dudek, L. Thuesen et al., "Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the absorb cohort a trial," JACC: Cardiovascular Interventions, vol. 6, no. 10, pp. 999-1009, 2013.
29. C. V. Bourantas, M. I. Papafaklis, A. Kotsia et al., "Effect of the endothelial shear stress patterns on neointimal proliferation following drug-eluting bioresorbable vascular scaffold implantation: an optical coherence tomography study," JACC: Cardiovascular Interventions, vol. 7, no. 3, pp. 315-324, 2014.
30. A. L. Sisson, M. Schroeter, A. Lendlein, A. Lendlein, and A. Sisson, Eds., Handbook of Biodegradable Polymers, Wiley-VCH, 2011.
31. H.-H. Wang, X.-R. Zhou, Q. Liu, and G.-Q. Chen, "Biosynthesis of polyhydroxyalkanoate homopolymers by Pseudomonas putida," Applied Microbiology and Biotechnology, vol. 89, no. 5, pp. 1497-1507, 2011.
32. D. Hu, A.-L. Chung, L.-P. Wu et al., "Biosynthesis and characterization of polyhydroxyalkanoate block copolymer P3HB-b-P4HB," Biomacromolecules, vol. 12, no. 9, pp. 3166-3173, 2011.
33. S. F. Williams, S. Rizk, and D. P. Martin, "Poly-4-hydroxybutyrate (P4HB): a new generation of resorbable medical devices for tissue repair and regeneration," Biomedizinische Technik, vol. 58, no. 5, pp. 439-452, 2013.
34. W. J. van der Giessen, A. M. Lincoff, R. S. Schwartz et al., "Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries," Circulation, vol. 94, no. 7, pp. 1690-1697, 1996.
35. A. Hezi-Yamit, C. Sullivan, J. Wong et al., "Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design," Journal of Biomedical Materials Research Part A, vol. 90, no. 1, pp. 133-141, 2009.
36. K. Ceonzo, A. Gaynor, L. Shaffer, K. Kojima, C. A. Vacanti, and G. L. Stahl, "Polyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation," Tissue Engineering, vol. 12, no. 2, pp. 301-308, 2006.
37. S. Commandeur, H. M. M. van Beusekom, and W. J. van der Giessen, "Polymers, drug release, and drug-eluting stents," Journal of Interventional Cardiology, vol. 19, no. 6, pp. 500-506, 2006.
38. P. W. Serruys and N. Kukreja, "Late stent thrombosis in drugeluting stents: return of the 'VB syndrome'," Nature Clinical Practice Cardiovascular Medicine, vol. 3, no. 12, article 637, 2006.
39. E. Grube, U. Gerckens, R. Müller, and L. Büllesfeld, "Drug eluting stents: initial experiences," Zeitschrift für Kardiologie, vol. 91, no. 3, pp. 44-48, 2002.
40. N. Kukreja, Y. Onuma, J. Daemen, and P.W. Serruys, "The future of drug-eluting stents," Pharmacological Research, vol. 57, no. 3, pp. 171-180, 2008.
41. A. T. L. Ong and P.W. Serruys, "Technology insight: an overview of research in drug-eluting stents," Nature Clinical Practice Cardiovascular Medicine, vol. 2, no. 12, pp. 647-658, 2005.
42. M. J. Patel, S. S. Patel, N. S. Patel, and N.M. Patel, "Current status and future prospects of drug eluting stents for restenosis," Acta Pharmaceutica, vol. 62, no. 4, pp. 473-496, 2012.
43. D. Sun, Y. Zheng, T. Yin, C. Tang, Q. Yu, and G. Wang, "Coronary drug-eluting stents: from design optimization to newer strategies," Journal of Biomedical Materials Research Part A, vol. 102, no. 5, pp. 1625-1640, 2014.
44. E. P. Navarese, F. Castriota, G. M. Sangiorgi, and A. Cremonesi, "From the abluminal biodegradable polymer stent to the polymer free stent. Clinical evidence," Minerva Cardioangiologica, vol. 61, no. 2, pp. 243-254, 2013.
45. E.P. Navarese, M. Kowalewski, B. Cortese et al., "Short andlongterm safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. Acomprehensive meta-analysis of randomized trials including 6178 patients," Atherosclerosis, vol. 233, no. 1, pp. 224-231, 2014.
46. T. Stiermaier, A. Heinz, D. Schloma et al., "Five-year clinical follow-up of a randomized comparison of a polymerfree sirolimus-eluting stent versus a polymer-based paclitaxeleluting stent in patients with diabetes mellitus (LIPSIA Yukon trial)," Catheterization and Cardiovascular Interventions, vol. 83, no. 3, pp. 418-424, 2014.
47. P. W. Serruys, S. Silber, S. Garg et al., "Comparison of zotarolimus-eluting and everolimus-eluting coronary stents," The New England Journal of Medicine, vol. 363, no. 2, pp. 136-146, 2010.
48. S. Silber, S. Windecker, P. Vranckx, and P. W. Serruys, "Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial," The Lancet, vol. 377, no. 9773, pp. 1241-1247, 2011.
49. Y. J. Youn, J.-W. Lee, S. G. Ahn et al., "Study design and rationale of a multicenter, open-labeled, randomized controlled trial comparing three 2nd-generation drug-eluting stents in realworld practice (CHOICE trial)," American Heart Journal, vol. 166, no. 2, pp. 224-229, 2013.
50. S. Petersen, J. Hussner, T. Reske et al., "In vitro study of dual drug-eluting stents with locally focused sirolimus and atorvastatin release," Journal of Materials Science: Materials in Medicine, vol. 24, no. 11, pp. 2589-2600, 2013.
51. S. Petersen, A. Strohbach, R. Busch, S. B. Felix, K.-P. Schmitz, and K. Sternberg, "Site-selective immobilization of anti-CD34 antibodies to poly(l-lactide) for endovascular implant surfaces," Journal of Biomedical Materials Research, Part B: Applied Biomaterials, vol. 102, no. 2, pp. 345-355, 2014.
52. A. Colombo, J. Drzewiecki, A. Banning et al., "Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions," Circulation, vol. 108, no. 7, pp. 788-794, 2003.
53. G. W. Stone, S. G. Ellis, D. A. Cox et al., "A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease," The New England Journal of Medicine, vol. 350, no. 3, pp. 221-231, 2004.
54. I. T. Meredith, P. S. Teirstein, A. Bouchard et al., "Three-year results comparing platinum-chromium PROMUS element and cobalt-chromium XIENCE V everolimus-eluting stents in de novo coronary artery narrowing (from the PLATINUM trial)," The American Journal of Cardiology, vol. 113, no. 7, pp. 1117-1123, 2014.
55. K. Waseda, A. Miyazawa, J. Ako et al., "Intravascular ultrasound results from the endeavor IV trial: randomized comparison between zotarolimus- and paclitaxeleluting stents in patients with coronary artery disease," JACC: Cardiovascular Interventions, vol. 2, no. 8, pp. 779-784, 2009.
56. M. B. Leon, L. Mauri, J. J. Popma et al., "A randomized comparison of the endeavor zotarolimus-eluting stent versus the taxus paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the endeavor iv trial," Journal of the American College of Cardiology, vol. 55, no. 6, pp. 543-554, 2010.
57. T. Watanabe, M. Fujita, M. Awata et al., "Integrity of stent polymer layer after drug-eluting stent implantation: in vivo comparison of sirolimus-, paclitaxel-, zotarolimus- and everolimuseluting stents," Cardiovascular Intervention and Therapeutics, vol. 29, no. 1, pp. 4-10, 2014.
58. Y. Onuma, N. Kukreja, N. Piazza et al., "The everolimus-eluting stent in real-world patients: 6-month follow-up of the x-search (xience v stent evaluated at rotterdamcardiac hospital) registry," Journal of the American College of Cardiology, vol. 54, no. 3, pp. 269-276, 2009.
59. S. Verheye, P. Agostoni, K. D. Dawkins et al., "The genesis (randomized, multicenter study of the pimecrolimus-eluting and pimecrolimus/paclitaxel-eluting coronary stent system in patients with de novo lesions of the native coronary arteries) trial," JACC: Cardiovascular Interventions, vol. 2, no. 3, pp. 205-214, 2009.
60. S. Windecker, P.W. Serruys, S. Wandel et al., "Biolimus-eluting stentwith biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial," The Lancet, vol. 372, no. 9644, pp. 1163-1173, 2008.
61. M. C. Ostojic, Z. Perisic, D. Sagic et al., "The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: the Stealth PK Study," European Journal of Clinical Pharmacology, vol. 67, no. 4, pp. 389-398, 2011.
62. G. G. Stefanini, B. Kalesan, P. W. Serruys et al., "Longterm clinical outcomes of biodegradable polymer biolimuseluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial," The Lancet, vol. 378, no. 9807, pp. 1940-1948, 2011.
63. E. Romagnoli, A. M. Leone, F. Burzotta et al., "Outcomes of the tacrolimus drug-eluting Janus stent: a prospective twocentre registry in high-risk patients," Journal of Cardiovascular Medicine, vol. 9, no. 6, pp. 589-594, 2008.
64. J. Iqbal, J. Gunn, and P.W. Serruys, "Coronary stents: historical development, current status and future directions," British Medical Bulletin, vol. 106, no. 1, pp. 193-211, 2013.
65. E. J. Smith, A. K. Jain, and M. T. Rothman, "New developments in coronary stent technology," Journal of Interventional Cardiology, vol. 19, no. 6, pp. 493-499, 2006.
66. H. Schühlen, A. Kastrati, J. Mehilli et al., "Restenosis detected by routine angiographic follow-up and late mortality after coronary stent placement," American Heart Journal, vol. 147, no. 2, pp. 317-322, 2004.
67. C. Chaabane, F. Otsuka, R. Virmani, and M.-L. Bochaton-Piallat, "Biological responses in stented arteries," Cardiovascular Research, vol. 99, no. 2, pp. 353-363, 2013.
68. R. Fattori and T. Piva, "Drug-eluting stents in vascular intervention," The Lancet, vol. 361, no. 9353, pp. 247-249, 2003.
69. H. M. Burt and W. L. Hunter, "Drug-eluting stents: amultidisciplinary success story," Advanced Drug Delivery Reviews, vol. 58, no. 3, pp. 350-357, 2006.
70. R. S. Schwartz, E. R. Edelman, A. Carter et al., "Drug-eluting stents in preclinical studies recommended evaluation from a consensus group," Circulation, vol. 106, no. 14, pp. 1867-1873, 2002.
71. F. Otsuka, A. V. Finn, S. K. Yazdani, M. Nakano, F. D. Kolodgie, and R. Virmani, "The importance of the endothelium in atherothrombosis and coronary stenting," Nature Reviews Cardiology, vol. 9, no. 8, pp. 439-453, 2012.
72. T. Tada and M. A. Reidy, "Endothelial regeneration. IX. Arterial injury followed by rapid endothelial repair induces smooth muscle-cell proliferation but not intimal thickening," American Journal of Pathology, vol. 129, no. 3, pp. 429-433, 1987.
73. F. N. G. Doornekamp, C. Borst, and M. J. Post, "The influence of lesion length on intimal hyperplasia after fogarty balloon injury in the rabbit carotid artery: role of endothelium," Journal of Vascular Research, vol. 34, no. 4, pp. 260-266, 1997.
74. M. Gouverneur, B. van den Berg, M. Nieuwdorp, E. Stroes, and H. Vink, "Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress," Journal of Internal Medicine, vol. 259, no. 4, pp. 393-400, 2006.
75. T. Asahara, H. Masuda, T. Takahashi et al., "Bonemarroworigin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization," Circulation Research, vol. 85, no. 3, pp. 221-228, 1999.
76. M. Joner, G. Nakazawa, A. V. Finn et al., "Endothelial cell recovery between comparator polymer-based drug-eluting stents," Journal of the American College of Cardiology, vol. 52, no. 5, pp. 333-342, 2008.
77. D. F. Williams, "On the mechanisms of biocompatibility," Biomaterials, vol. 29, no. 20, pp. 2941-2953, 2008.
78. R. S. O'Connor, X. Hao, K. Shen et al., "Substrate rigidity regulates human T cell activation and proliferation," Journal of Immunology, vol. 189, no. 3, pp. 1330-1339, 2012.
79. R. Busch, A. Strohbach, S. Peterson, K. Sternberg, and S. Felix, "Parameters of endothelial function are dependent on polymeric surface material," Biomedical Engineering/Biomedizinische Technik, 2013.
80. R. Busch, A. Strohbach, S. Rethfeldt et al., "New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets," Acta Biomaterialia, vol. 10, no. 2, pp. 688-700, 2014.
81. H. M. M. van Beusekom, D. M. Whelan, S. H. Hofma et al., "Long-term endothelial dysfunction is more pronounced after stenting than after balloon angioplasty in porcine coronary arteries," Journal of the American College of Cardiology, vol. 32, no. 4, pp. 1109-1117, 1998.
82. P. M. Vanhoutte, "Endothelial dysfunction-the first step toward coronary arteriosclerosis," Circulation Journal, vol. 73, no. 4, pp. 595-601, 2009.
83. D. A. Duprez, "Arterial stiffness and endothelial function: key players in vascular health," Hypertension, vol. 55, no. 3, pp. 612-613, 2010.
84. J. A. Wood, N. M. Shah, C. T. McKee et al., "The role of substratumcompliance of hydrogels on vascular endothelial cell behavior," Biomaterials, vol. 32, no. 22, pp. 5056-5064, 2011.
85. X. Peng, S. Haldar, S. Deshpande, K. Irani, and D. A. Kass, "Wall stiffness suppresses Akt/eNOS and cytoprotection in pulseperfused endothelium," Hypertension, vol. 41, no. 2, pp. 378-381, 2003.
86. A. J. Engler, M. A. Griffin, S. Sen, C. G. Bönnemann, H. L. Sweeney, and D. E. Discher, "Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments," Journal of Cell Biology, vol. 166, no. 6, pp. 877-887, 2004.
87. F. Rehfeldt, A. J. Engler, A. Eckhardt, F. Ahmed, and D. E. Discher, "Cell responses to the mechanochemical microenvironment-implications for regenerative medicine and drug delivery," Advanced Drug Delivery Reviews, vol. 59, no. 13, pp. 1329-1339, 2007.
88. K. Kulangara, Y. Yang, J. Yang, and K.W. Leong, "Nanotopography as modulator of human mesenchymal stem cell function," Biomaterials, vol. 33, no. 20, pp. 4998-5003, 2012.
89. K. Kulangara, A. F. Adler, H. Wang et al., "The effect of substrate topography on direct reprogramming of fibroblasts to induced neurons," Biomaterials, vol. 35, no. 20, pp. 5327-5336, 2014.
90. Y. L. Jung and H. J. Donahue, "Cell sensing and response to micro- and nanostructured surfaces produced by chemical and topographic patterning," Tissue Engineering, vol. 13, no. 8, pp. 1879-1891, 2007.
91. D.M. Le, K. Kulangara, A. F. Adler, K.W. Leong, and V.S. Ashby, "Dynamic topographical control of mesenchymal stem cells by culture on responsive poly(∈-caprolactone) surfaces," Advanced Materials, vol. 23, no. 29, pp. 3278-3283, 2011.
92. R. E. Gerszten, E. A. Garcia-Zepeda, Y.-C. Lim et al., "MCP- 1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions," Nature, vol. 398, no. 6729, pp. 718-725, 1999.
93. F. G. P. Welt and C. Rogers, "Inflammation and restenosis in the stent era," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 11, pp. 1769-1776, 2002.
94. H. C. Cohen, E. J. Joyce, and W. J. Kao, "Biomaterials selectively modulate interactions between human blood-derived polymorphonuclear leukocytes and monocytes," The American Journal of Pathology, vol. 182, no. 6, pp. 2180-2190, 2013.
95. A. P. Khandwekar, D. P. Patil, Y. Shouche, and M. Doble, "Surface engineering of polycaprolactone by biomacromolecules and their blood compatibility," Journal of Biomaterials Applications, vol. 26, no. 2, pp. 227-252, 2011.
96. H. M. Rinder, J. L. Bonan, C. S. Rinder, K. A. Ault, and B. R. Smith, "Dynamics of leukocyte-platelet adhesion in whole blood," Blood, vol. 78, no. 7, pp. 1730-1737, 1991.
97. J. M. Anderson, A. Rodriguez, and D. T. Chang, "Foreign body reaction to biomaterials," Seminars in Immunology, vol. 20, no. 2, pp. 86-100, 2008.
98. W.-B. Tsai, J. M. Grunkemeier, C. D. McFarland, and T. A. Horbett, "Platelet adhesion to polystyrene-based surfaces preadsorbed with plasmas selectively depleted in fibrinogen, fibronectin, vitronectin, or von Willebrand's factor," Journal of Biomedical Materials Research, vol. 60, no. 3, pp. 348-359, 2002.
99. N. Swansons and A. Gershlick, "Glycoprotein (GP) IIb/IIIa receptor antagonist eluting stents," in Local Drug Delivery for Coronary Artery Disease: Established and Emerging Applications, Taylor & Francis, 2005.
100. H. Nygren, "Initial reactions of whole blood with hydrophilic and hydrophobic titanium surfaces," Colloids and Surfaces B: Biointerfaces, vol. 6, no. 4-5, pp. 329-333, 1996.
101. J. H. Lee and H. B. Lee, "Platelet adhesion onto wettability gradient surfaces in the absence and presence of plasma proteins," Journal of Biomedical Materials Research, vol. 41, no. 2, pp. 304-311, 1998.
102. R. K. Aggarwal, D. C. Ireland, M. A. Azrin, M. D. Ezekowitz, D. P. de Bono, and A. H. Gershlick, "Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody," Circulation, vol. 94, no. 12, pp. 3311-3317, 1996.
103. H. Xu, K. T. Nguyen, E. S. Brilakis, J. Yang, E. Fuh, and S. Banerjee, "Enhanced endothelialization of a new stent polymer through surface enhancement and incorporation of growth factor-delivering microparticles," Journal of Cardiovascular Translational Research, vol. 5, no. 4, pp. 519-527, 2012.
104. L. Mao, L. Shen, J. Niu et al., "Nanophasic biodegradation enhances the durability and biocompatibility of magnesium alloys for the next-generation vascular stents," Nanoscale, vol. 5, no. 20, pp. 9517-9522, 2013.
105. M. Sgarioto, R. Adhikari, P. A. Gunatillake et al., "Properties and in vitro evaluation of high modulus biodegradable polyurethanes for applications in cardiovascular stents," Journal of Biomedical Materials Research, Part B: Applied Biomaterials, vol. 102, no. 8, pp. 1711-1719, 2014.
106. Y. Mukai, C.-Y. Wang, Y. Rikitake, and J. K. Liao, "Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells," American Journal of Physiology-Heart and Circulatory Physiology, vol. 292, no. 4, pp. H1937-H1942, 2007.
107. J. Partridge, H. Carlsen, K. Enesa et al., "Laminar shear stress acts as a switch to regulate divergent functions of NF-κB in endothelial cells," The FASEB Journal, vol. 21, no. 13, pp. 3553-3561, 2007.
108. X. Ling, J.-F. Ye, and X.-X. Zheng, "Dynamic investigation of leukocyte-endothelial cell adhesion interaction under fluid shear stress in vitro," Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao, vol. 35, no. 6, pp. 567-572, 2003.
109. L. J. Taite, M. L. Rowland, K. A. Ruffino, B. R. E. Smith, M. B. Lawrence, and J. L. West, "Bioactive hydrogel substrates: probing leukocyte receptor-ligand interactions in parallel plate flowchamber studies," Annals of Biomedical Engineering, vol. 34, no. 11, pp. 1705-1711, 2006.
110. T. R. Dunkern, M. Paulitschke, R. Meyer et al., "A novel perfusion system for the endothelialisation of PTFE grafts under defined flow," European Journal of Vascular and Endovascular Surgery, vol. 18, no. 2, pp. 105-110, 1999.
111. A. Rademacher, M. Paulitschke, R. Meyer, and R. Hetzer, "Endothelialization of PTFE vascular grafts under flow induces significant cell changes," International Journal of Artificial Organs, vol. 24, no. 4, pp. 235-242, 2001.
112. A. Neubert, K. Sternberg, S. Nagel et al., "Development of a vessel-simulating flow-through cell method for the in vitro evaluation of release and distribution from drug-eluting stents," Journal of Controlled Release, vol. 130, no. 1, pp. 2-8, 2008.
113. A. Seidlitz, S. Nagel, B. Semmling et al., "Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell," European Journal of Pharmaceutics and Biopharmaceutics, vol. 78, no. 1, pp. 36-48, 2011.
114. K. R. Kamath, J. J. Barry, and K. M. Miller, "The Taxus drugeluting stent: a new paradigm in controlled drug delivery," Advanced Drug Delivery Reviews, vol. 58, no. 3, pp. 412-436, 2006.
115. M. E. McCormick, R. Goel, D. Fulton, S. Oess, D. Newman, and E. Tzima, "Platelet-endothelial cell adhesion molecule- 1 regulates endothelial NO synthase activity and localization through signal transducers and activators of transcription 3-dependent NOSTRIN expression," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 3, pp. 643-649, 2011.
116. G. Nakazawa, J. F. Granada, C. L. Alviar et al., "Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization," JACC: Cardiovascular Interventions, vol. 3, no. 1, pp. 68-75, 2010.
117. A. Simon, T. Cohen-Bouhacina, M. C. Porté et al., "Characterization of dynamic cellular adhesion of osteoblasts using atomic force microscopy," Cytometry A, vol. 54, no. 1, pp. 36-47, 2003.
118. E. Takai, K. D. Costa, A. Shaheen, C. T. Hung, and X. E. Guo, "Osteoblast elastic modulus measured by atomic force microscopy is substrate dependent," Annals of Biomedical Engineering, vol. 33, no. 7, pp. 963-971, 2005.
119. J. Goldman, "Abrief resume of clinical observations in the treatment of superficial burns, trigeminal neuralgia, acute bursitis, and acute musculo-skeletal trauma with dimethyl sulfoxide," Annals of the New York Academy of Sciences, vol. 141, no. 1, pp. 653-654, 1967.
120. M. B. Lawrence, "In vitro flow models of leukocyte adhesion," in Physiology of Inflammation, K. Ley, Ed., Oxford University Press, New York, NY, USA, 2001.
121. X. Chang and M. Gorbet, "The effect of shear on in vitro platelet and leukocyte material-induced activation," Journal of Biomaterials Applications, vol. 28, no. 3, pp. 407-415, 2013.
122. M. M. M. Bilek, D. V. Bax, A. Kondyurin et al., "Free radical functionalization of surfaces to prevent adverse responses to biomedical devices," Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 35, pp. 14405-14410, 2011.
123. G. V. R. Born, "Aggregation of blood platelets by adenosine diphosphate and its reversal," Nature, vol. 194, no. 4832, pp. 927-929, 1962.